Mary Slatter

Royal Children's Hospital — Australia

Immunology and Microbiology · Life Sciences

56h-index10.5kcitations218works5.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunodeficiency and Autoimmune Disorders(134), Hematopoietic Stem Cell Transplantation(87), Blood disorders and treatments(44), Cytomegalovirus and herpesvirus research(37), Immune Cell Function and Interaction(36)

Publications215 total

Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study
Blood Advances·2025· 2 citedOpen Access
Low rates of endothelial cell dysfunction and transplant‐related mortality in 537 children receiving fludarabine–treosulfan conditioning for all transplant indications: A retrospective multicentre study on behalf of the <scp>UK</scp> Paediatric <scp>BMT</scp> group
British Journal of Haematology·2025· 2 citedOpen Access
7826 A single tertiary centre experience of paediatric patients receiving fertility cryopreservation prior to allogeneic haematopoietic stem cell transplant (HSCT)
2025
HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study
Blood·2025· 4 cited
Outcomes of Hematopoietic Stem Cell Transplantation in 5 Patients with Autosomal Recessive RIPK1-Deficiency
Journal of Clinical Immunology·2025· 5 citedOpen Access
The Power of Partnership: Redefining Research in Paediatric Haematopoietic Stem Cell Transplantation
SSRN Electronic Journal·2025Open Access
Significant Incidence of Mixed Donor Chimerism Despite TBI Conditioning in Paediatric B-ALL Patients Bridged to Transplant with Blinatumomab - a Report from the UK and Ireland Paediatric Bone Marrow Transplant/Cellular Therapies Group
Blood·2024Open Access
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) Outcomes in Leukocyte Adhesion Deficiency Type -I
Blood·2024Open Access
OUTCOME OF PATIENTS WITH SIGNAL-TRANSDUCER AND ACTIVATOR OF OF TRANSCRIPTION 1 MUTATIONS (STAT1) GAIN-OF-FUNCTION VARIANTS AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION - AN IEWP/PIDTC STUDY
Bursa Uludag University - AVESIS·2024
Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity
Blood Advances·2024· 7 citedOpen Access
Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party study
Journal of Allergy and Clinical Immunology·2024· 11 citedOpen Access
Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency—Centromeric Instability—Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study
Journal of Clinical Immunology·2024· 5 citedOpen Access
CD3<sup>+</sup>TCRαβ/CD19<sup>+</sup>‐depleted stem cell boost and CD45RO<sup>+</sup> memory T‐cell add‐back as a successful salvage treatment for poor graft function unresponsive to eltrombopag, following a second allogenic HSCT
Pediatric Blood & Cancer·2024
A de novo TLR7 gain-of-function mutation causing severe monogenic lupus in an infant
Journal of Clinical Investigation·2024· 25 citedOpen Access
Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity
Blood·2024· 17 cited
Expanding the PRAAS spectrum: De novo mutations of immunoproteasome subunit β-type 10 in six infants with SCID-Omenn syndrome
The American Journal of Human Genetics·2024· 20 citedOpen Access
P25 Two cases of multicentric dermatofibrosarcoma Protuberans (DFSP) and adenosine deaminase deficient-severe combined immunodeficiency (ADA-SCID) in a tertiary centre
British Journal of Dermatology·2024
Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow Grafts
Transplantation and Cellular Therapy·2023· 5 citedOpen Access
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study
Journal of Allergy and Clinical Immunology·2023· 52 citedOpen Access
Too much of a good thing: a review of primary immune regulatory disorders
Frontiers in Immunology·2023· 14 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Andrew R. Gennery(41), Paul Veys(21), Andrew J. Cant(17), Bénédicte Neven(15), Ansgar Schulz(15), Alain Fischer(13), Tayfun Güngör(12), Michael H. Albert(12), Despina Moshous(12), Petr Sedláček(11), Marina Cavazzana(11), Mario Abinun(11), Robbert G. M. Bredius(10), Krzysztof Kałwak(10), Luigi D. Notarangelo(9), Arjan C. Lankester(9), Christopher C. Dvorak(9), Kanchan Rao(9), Fulvio Porta(8), Sophie Hambleton(8)